April 2018 Berberine derivatives are present at IX WDD-2018 Congress


Dr. Paolo Lombardi, CEO of Naxospharma and former collaborator of AROMICS will present the advances of Berberine and novel derivatives as therapy for treating cancer.

Dr. Lombardi is one of the participants of the World DNA Day, the most influential congress that BIT organized in the past 14 years. The aim of BIT's 9th Anniversary World DNA Day-2018 (WDD-2018) is to follow up the commemoration of the 65th anniversary of the publication of DNA double-helix structure in Nature from April 25, 1953 by Dr. James Watson and Dr. Francis Crick. WDD-2018, which will be held during April 25-27, 2018 in Dalian, China.